Related Experiment Video
Updated: Aug 7, 2025

09:14
An In Vitro System to Study Tumor Dormancy and the Switch to Metastatic Growth
Published on: August 11, 2011
15.9K
State-dependent evolutionary models reveal modes of solid tumour growth
Maya A Lewinsohn1,2, Trevor Bedford3,4,5, Nicola F Müller6
1Department of Genome Sciences, University of Washington, Seattle, WA, USA. lewinsom@uw.edu.
Nature Ecology & Evolution
|March 9, 2023
Summary
Tumor cells divide faster on the periphery, leaving genetic patterns that reveal growth rates. A new phylodynamic model, SDevo, quantifies these patterns to study tumor spatial evolution.
Area of Science:
- Oncology
- Evolutionary Biology
- Computational Biology
Background:
- Spatial tumor growth influences cancer progression, treatment resistance, and metastasis.
- Quantifying spatial variations in tumor cell division rates within clinical tumors is challenging.
Purpose of the Study:
- To develop a method for inferring differential cell division rates based on spatial position within tumors.
- To analyze genetic patterns indicative of faster peripheral tumor cell division.
Main Methods:
- Reconstruction of phylogenetic trees from spatially sampled tumor cells.
- Development of a Bayesian state-dependent evolutionary phylodynamic model (SDevo).
- Application of SDevo to simulated and clinical hepatocellular carcinoma (HCC) data.
Main Results:
- Faster-dividing peripheral tumor lineages exhibit more branching and mutations in phylogenetic trees.
- SDevo accurately infers spatially varying birth rates in simulated tumors.
- Clinical HCC data reveal a 3-6 times higher division rate on the tumor edge compared to the center.
Conclusions:
- Spatial position significantly impacts tumor cell division rates, with faster growth at the periphery.
- The SDevo model provides a robust tool for analyzing spatial tumor evolution using multi-region sequencing data.
- This approach can enhance understanding of spatial growth restrictions and inform future cancer research.
More Related Videos
Related Concept Videos
Tumor Progression
6.4K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.4K
Adaptive Mechanisms in Cancer Cells
5.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.9K
Cancer Stem Cells and Tumor Maintenance
5.0K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.0K
Cancer
49.0K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
49.0K
Cancers Originate from Somatic Mutations in a Single Cell
12.4K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
12.4K
Metastasis
5.6K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.6K

